| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP |
| Suitable for: | Adult |
| State: | Powder |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
| Product Name | Temozolomide |
| Appearance | White Power |
| CAS No. | 85622-93-1 |
| MF | C6H6N6O2 |
Temozolomide is an oral chemotherapy drug. It is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.
It is a treatment for newly diagnosed glioblastoma multiforme. You have it with radiotherapy and then once you have finished the radiotherapy treatment you continue taking it on its own.
It is also a treatment on its own for glioblastoma multiforme or anaplastic astrocytoma that has come back or where previous treatment didn't work.
Temozolomide is sometimes a treatment for bone sarcoma (cancer) that has come back. You usually have it with another drug called irinotecan.
Temozolomide can be used in treatment of Grade IV astrocytoma. Methylation damages the DNA and triggers the death of tumor cells,temozolomide's ability to alkylate/methylate DNA, which most often occurs at the N-7 or O-6 positions of guanine residues for the therapeutic benefit of temozolomide depends.
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}